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Objectives: This study aimed to investigate sex differences in fear of pain (FOP) measured 
by the Fear of Pain Questionnaire III (FPQ-III) in a nonclinical sample. The FPQ-III is a self-
report inventory measuring FOP, with 30 items, divided into three subscales: Severe, Minor 
and Medical Pain.
Methods: A total of 185 subjects participated (49.7% females) in this study. Sex differences 
on overall FOP, the subscales, and at item level were examined. One-way analysis of variance 
tested the association between sex and FOP, measured by overall FOP and the subscales. Ordinal 
regression analysis enabled item-level analysis of the FPQ-III and was conducted to explore 
further specificity of FOP in males compared to females.
Results: Overall FOP and fear of Severe Pain was significantly higher in females than in males, 
as measured by the FPQ-Total and the FPQ-Severe. Moreover, females were more likely to report 
higher FOP than males on 16 items (p<0.05). Further inspection revealed that females scored 
significantly higher than males on all items on the Severe Pain subscale. When controlling for 
multiple comparisons six items reached significance (p<0.001). Five of these items belonged 
to the subscale Severe Pain. When controlling for overall FOP one item, also from the Severe 
Pain subscale, reached significance (p<0.001).
Conclusion: There are sex differences in severe FOP, with higher FOP in females compared 
to males. Potential explanations are sex differences in the 1) psychosocial mechanisms of fear 
and anxiety, and 2) emotional reactions to and interpretation of FPQ-III Severe Pain items.
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Introduction
Fear of pain (FOP) and anxiety are often measured as covariates in experimental and 
clinical pain studies. Fear and anxiety are typically defined as related but distinct con-
structs, with fear representing an alarm reaction toward a presented threat, and anxiety 
a future-focused fear or worry.1 Previous studies have revealed that females are more 
sensitive to pain2 and have lower pain threshold and tolerance than their male peers.3 
A recent meta-analysis reviewing sex differences in experimental pain research con-
cluded that hormones and depression are not the contributing factors to sex differences 
in pain, but that anxiety, cognitive, and social factors are.4 FOP has been associated 
with increased sensitivity to pain and reduced pain threshold.5,6 There is an evidence 
for the existence of sex differences here as well, with findings suggesting that high 
levels of FOP reduce pain tolerance in females, but not in males.3 Other studies have 
reported that anxiety may increase pain1 and that anxiety is more strongly associated 
with pain in males than in females.2,7
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Sex differences in FOP measured by the Fear of Pain 
Questionnaire III (FPQ-III) have been reported in several 
studies,8–12 and the tendency is that FOP is higher in females 
than in males. Sullivan et al found sex differences in FPQ-
III endorsed FOP. However, FOP did not predict pain report, 
and anxiety was not correlated with FOP and pain report.10 
Moreover, by using path analyses, significant paths were 
found from trait to state anxiety, from trait anxiety to catastro-
phizing, and from catastrophizing to pain report. This could 
indicate that FOP has a stronger association with avoidance 
of pain, than the pain experience itself.13 Another possibility 
is that the measurement of FOP by the FPQ-III is too gen-
eral, as suggested by Sullivan et al.10 While these findings 
on sex differences in FOP could simply indicate that females 
fear pain to a greater degree than males, the composition of 
some questions on the FPQ-III, and their potential influence, 
should not be discounted. For example, some FPQ-III items 
describe situations that involve serious pain with poten-
tially fatal outcomes. If these items tend to evoke different 
responses in males and females, for example, FOP in males 
while females are more likely to experience anxiety or fear 
of dying, it may lead to sex differences in FOP reflected on 
FPQ-III measurements. Higher specificity at item level may 
address some of these uncertainties, and could potentially 
lead to a more precise measure of FOP in both males and 
females. Thus, the development of instruments for measur-
ing FOP that are sensitive enough to 1) detect FOP and 2) 
distinguish fear from other psychological measures such as 
anxiety in both males and females is important.
The FPQ-III has become a widely used assessment 
device for self-reported FOP in both clinical and nonclinical 
samples.12 While taking the FPQ-III, respondents are asked 
to rate their degree of fear toward certain imagined scenarios 
involving pain. The FPQ-III has three subscales: fear of 
Severe, Minor and Medical Pain, and the questionnaires’ 
psychometric properties have been investigated.11,12,14,15 Some 
studies have reported that the FPQ-III has a good internal 
consistency and moderate-to-good test–retest stability.12 
However, others have concluded that the model has a poor 
fit.14,16 As previously mentioned, sex differences in FOP mea-
sured by the FPQ-III have been reported repeatedly.8,11,12 Yet 
it should be noted that inconsistencies remain in the extant 
literature in this area, with some studies reporting sex dif-
ferences in overall FOP, while differences are limited to the 
subscales in other studies. However, throughout these studies 
the direction of the differences between males and females 
has remained consistent, with higher FOP in females than in 
males. To the best of our knowledge, no study has addressed 
sex differences related to measures of FOP by the FPQ-III 
through content item analysis to date. This study aims to 1) 
investigate sex differences in FOP measured by the FPQ-total, 
the FPQ-subscales and at FPQ-item-level and 2) assess the 
appropriateness of the significant items in relation to mea-
surements of pain. We hypothesized higher FOP in females 
than in males, and that this difference would be reflected by 
sex differences on FPQ-total, the subscales and at item level.
Methods
Participants
A total of 185 healthy college students were included in the 
study (49.7% females, mean age: 21, 62, range: 18–30 years; 
50.3% males, mean age: 24, range: 19–32 years). Data from 
three different samples were pooled. All the three studies 
were experimental pain studies. Subjects with previous or 
present serious injuries, psychological and/or physiological 
disorders were excluded from participation. The FPQ-III 
and an informed consent form were then filled in. The stud-
ies were approved by the Regional Committee for Medical 
Research Ethics North Norway.
Measures
The FPQ-III measures pain-related fear on a 30-item ques-
tionnaire.12 Each question presents a situation involving pain, 
and participants are asked to rate FOP on a 5-point Likert 
scale. High scores reflect high FOP (1= not afraid at all, 5= 
extremely afraid). Responders are asked to rate their FOP 
involved in the situations described, for example, breaking 
your neck. The scale is divided into three subscales consist-
ing of 10 questions, represented as Severe Pain (e.g., being 
involved in a car accident), Minor pain (e.g., biting your 
tongue), and Medical pain (e.g., receiving an injection in your 
mouth). The FPQ-III was designed to measure respondents’ 
FOP, clinically and nonclinically, in patients and healthy 
individuals.12 A Norwegian version of the FPQ-III, translated 
and back translated by Lyby et al, was used in this study.17
Statistical analyses
One-way analysis of variance (ANOVA) with FPQ-III Total 
score and FPQ-III Severe Pain score as outcomes were 
conducted to examine overall endorsed FOP. An ordinal 
regression analysis was conducted to further explore the 
specificity of FOP in males versus females by examining 
the FPQ-III on an item-level basis. The item-level analysis 
might provide more specific measures of endorsed FOP than 
subscale analysis. The ordinal regression analysis was first 
conducted without controlling for FPQ-III Total score. After 
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which, the second analysis was performed while controlling 
for the FPQ-III Total score. The FPQ-III Total score was 
centered to the unweighted mean of the FPQ-III Total mean 
value for males and females. Females were used as reference 
group, leading to interpretation of the beta with a focus on 
female advantage (less likely to score higher than males, 
positive beta) or disadvantage (more likely to score higher 
than males, negative beta). Bonferroni correction for multiple 
comparisons was applied and the α-level was set to 0.001.
Results
One-way ANOVAs were conducted to analyze sex differ-
ences in FOP measured by FPQ-III Total and the subscales. 
In line with aim (1) statistically significant differences 
between males and females on FPQ-III Total scores were 
found (F(1,184)=12.29, p=0.001). Descriptive statistics 
showed that this was due to higher FPQ-III scores in females 
(m=77.3) than in males (m=69.3). The difference between 
males and females on the Severe Pain subscale was also sig-
nificant (F(1,184)=24.18, p<0.001). Again, females scored 
significantly higher than males. No significant sex differences 
were found on the subscales Medical Pain (F(1,184)=2.37, 
p=0.125) and Minor Pain (F(1,184)=2.44, p=0.119). Mean 
scores and standard deviations for males and females are 
presented in Table 1.
An ordinal regression analysis, without controlling 
for overall FOP (FPQ-III Total), but adjusted for multiple 
comparisons, revealed that females were significantly more 
likely to score higher than males on six items (p<0.001). 
Among these, five items were categorized as Severe Pain 
and one item as Minor Pain. Thus, females scored signifi-
cantly higher than males on half of the items constituting 
the Severe Pain subscale. Seven more items were signifi-
cant on p=0.05 (Table 1). Closer inspection revealed that 
on p<0.05, all items on the Severe Pain subscale reached 
significance.
When controlling for overall FOP, one item, a Severe 
Pain subscale item (item 10), met significance at p<0.001. 
However multiple items were significant at p<0.050 (items 1, 
5, 12, 15, 22, and 29). Among these items, two were Severe, 
two were Medical, and two were Minor Pain subscale items. 
Females scored lower FOP than males on the two Medical 
Pain subscale items, as indicated by the positive beta weights 
(items 15 and 29) (Table 2).
Discussion
This study revealed sex differences in FOP as shown by the 
relatively higher FPQ-III scores in females compared to 
males. In this sample, females had higher overall FOP and 
more fear of Severe Pain, as measured by FPQ-III Total and 
FPQ-III Severe Pain. Further inspection revealed that the 
sex differences in fear of Severe Pain influenced the measure 
of overall FOP. Thus, suggesting that the sex differences on 
FPQ-III Total were due to sex differences on Severe Pain 
subscale items. The higher FOP in females than in males 
found in the present study is in line with previous studies.14,15
To quickly summarize some of the findings from previ-
ous studies on the FPQ-III, McNeil and Rainwater reported 
sex differences on overall, Severe, Medical, and Minor Pain 
subscales.12 Osman et al reported sex differences on the 
Severe and Medical Pain subscales.11 Others have reported 
sex differences on the Severe Pain subscale only.8 These 
studies clearly agree that sex differences in FOP as measured 
by the FPQ-III exist, and that FOP is higher in females than 
males. To our knowledge, no studies have reported higher 
FOP in males than in females on overall or subscale levels, 
yet inconsistencies persist across studies regarding how these 
differences are expressed.
One possible explanation of the observed sex differ-
ence in fear of Severe Pain is that some of the items might 
reflect psychological measures other than FOP in females. 
An increasing number of studies have shown that pain and 
psychological measures such as fear and anxiety are closely 
related, and that their association with, or relationship to, 
pain may differ between males and females.2,7,18 While 
anxiety has been found to increase pain in both sexes, the 
association between pain and anxiety is stronger in males 
than in females.18 Accordingly, higher levels of anxiety are 
more strongly associated with higher levels of pain in males 
than in females. In chronic pain patients, overall anxiety 
sensitivity is higher in females than in males, but males have 
higher levels of pain-related anxiety, than females.2 Further-
more, high levels of FOP reduce pain tolerance in females, 
but not in males.3 This could explain why females express 
higher levels of stress, anxiety, and increased negative affect 
compared to males,19 and may be relevant for understanding 
the findings from this study. In our sample, females scored 
significantly higher than males on the Severe Pain subscale. 
Table 1 Participant demographics
Total Male Female
N 185 93 92
Mean of FPQ-III Total (SD) 73.3 (15.7) 69.3 (15.9) 77.3 (14.6)
Mean of FPQ-III Severe (SD) 32.5 (7.5) 30.0 (7.4) 35.2 (6.9)
Mean of FPQ-III Medical (SD) 22.8 (6.7) 22.0 (6.6) 23.6 (6.8)
Mean of FPQ-III Minor (SD) 17.9 (5.3) 17.3 (5.7) 18.5 (4.9)
Abbreviations: FPQ III, Fear of Pain Questionnaire III; SD, standard division.





We  hypothesized that the Severe Pain subscale items could 
have been interpreted or understood differently in males and 
females, possibly due to divergent levels of overall anxiety 
and pain-related anxiety. This may in turn have produced 
the observed sex differences. Some of the most contrast-
ing effects between males and females were found in their 
responses to Severe Pain subscale items, which included item 
1 (“automobile accident”), 13 (“breaking your neck”), and 
25 (“having a terminal illness causing daily pain”). Females’ 
responses to these items might reflect more symptoms of 
anxiety rather than FOP itself. Previous studies have reported 
that females are, for example, more afraid of dying compared 
to males.20,21 Therefore, females may be more fearful of seri-
ous incidents, and thereby respond with higher FOP than 
males to such items. Females’ responses to these items might 
therefore more accurately reflect higher levels of anxiety 
than FOP. Thus, the Severe Pain subscale may potentially 
measure something other than FOP in females than in males, 
such as fear of dying, fear of being disabled, overall anxiety, 
or existential anxiety. This study defined fear and anxiety as 
related constructs, but with some distinctions. The findings 
of higher levels of severe FOP in females, might be related 
to the interpretation of the Severe Pain subscale items. For 
example, “Being in an automobile accident”, “Having a 
heavy object hit you in the head”, “Breaking your neck”, and 
“Having a terminal illness that causes you daily pain” might 
not only represent FOP. Such items could also elicit anxiety 
related to the consequences and implications these serious 
happenings might have effect on, for example, familial fac-
tors and caregiver responsibilities.
One of the FPQ-III items involve daily pain as a comor-
bidity to terminal illness. Most healthy individuals have no 
Table 2 Item-level analysis FPQ-III
Item (2a) Main effect of gendera (2b) Main effect of genderb
b SE p-Value b SE p-Value
Car accident (Severe) −1.10 0.278 <0.001* −0.73 0.293 0.012**
Biting tongue (Minor) −0.38 0.279 0.171 0.16 0.300 0.958
Breaking arm (Severe) −0.56 0.268 0.037** −0.13 0.283 0.655
Cut tongue on envelope (Minor) −0.13 0.271 0.617 0.33 0.289 0.256
Heavy object head (Severe) −0.97 0.271 <0.001* −0.59 0.283 0.038**
Break leg (Severe) −0.66 0.268 0.014** −0.21 0.280 0.457
Hit elbow (Minor) −0.41 0.277 0.134 0.12 0.297 0.679
Blood sample (Medical) −0.03 0.279 0.927 0.48 0.303 0.112
Slam car door hand (Severe) −0.78 0.270 0.004** −0.47 0.282 0.096
Fall down stairs (Severe) −1.16 0.278 <0.001* −0.92 0.290 <0.001*
Injection arm (Medical) −0.21 0.274 0.439 0.39 0.299 0.189
Burn fingers (Minor) −0.08 0.282 0.774 0.79 0.331 0.017**
Break neck (Severe) −0.74 0.285 0.010** −0.30 0.307 0.324
Injection hip (Medical) −0.50 0.267 0.059 0.08 0.283 0.786
Splinter in foot removed (Medical) 0.14 0.288 0.619 0.65 0.319 0.042**
Remove particle from eye (Medical) −0.20 0.263 0.446 0.32 0.279 0.256
Injection mouth (Medical) −0.18 0.265 0.489 0.36 0.285 0.207
Face burned by cigarette (Severe) −0.71 0.272 0.009** −0.33 0.282 0.238
Paper-cut finger (Minor) −0.23 0.284 0.409 0.41 0.322 0.202
Stitches lip (Medical) −0.42 0.268 0.114 0.04 0.287 0.875
Remove foot wart (Medical) −0.66 0.274 0.015** −0.21 0.295 0.481
Shaving cut (Minor) −1.35 0.300 <0.001* −0.96 0.324 0.003**
Hot drink (Minor) −0.18 0.280 0.526 0.34 0.299 0.261
Soap eyes (Minor) −0.31 0.291 0.286 −0.01 0.309 0.981
Terminal illness (Severe) −0.95 0.281 <0.001* −0.58 0.301 0.054
Tooth pulled (Medical) −0.34 0.264 0.195 0.23 0.282 0.407
Vomiting food poisoning (Severe) −0.93 0.275 <0.001* −0.50 0.286 0.081
Sand eyes (Minor) 0.31 0.272 0.257 0.18 0.296 0.531
Tooth drilled (Medical) 0.17 0.265 0.512 0.66 0.283 0.018**
Muscle cramp (Minor) −0.67 0.277 0.015** −0.22 0.292 0.452
Notes: b negative values indicate females score higher than males; b positive values indicate females score lower than males. aMain effect of gender without controlling for 
overall fear of pain. bMain effect of gender controlling for overall fear of pain. *Significant p<0.050. **Significant after Bonferroni adjustment (p<0.001).
Abbreviations: FPQ III, Fear of Pain Questionnaire III; SE, standard error.
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experience with pain related to this terminal illness. This is 
highly relevant for the sample in this study, which consisted 
of young, healthy participants (mean age: 22.8 years). It is 
likely that these items measure anxiety, for example, and 
not the FOP associated with the specific situation. Females 
report more fear and score higher on measures of trait anxiety 
than males.22 Thus, these items may be problematic when the 
FPQ-III is utilized to measure FOP in healthy individuals. The 
finding of less pronounced sex differences on the subscales 
with less serious outcomes, again raises the question if higher 
levels of anxiety in females than in males might influence 
the Severe Pain subscale. Sex differences in interpretations 
of possible consequences from the presented situations may 
explain this finding. Furthermore, specificity of some of the 
FPQ items could improve the ability to measure FOP equally 
in healthy males and females. Exchanging items where large 
sex differences are expressed, with other items describing 
situations where severe pain is involved, might improve the 
FPQ-III’s ability to measure FOP more equally in males and 
females. As previously mentioned, most healthy individuals 
have no experience with or relation to serious accidents 
or injuries, such as one may expect after a car accident or 
breaking the neck. It may be argued that the Severe Pain sub-
scale does not present situations exclusively related to pain 
infliction. Inclusion of items presenting other pain involving 
situations may be more appropriate in relation to measure-
ments of pain and FOP. A possible way of further developing 
the FPQ-III could be to exchange some of these items with 
other items that healthy participants more easily can relate 
to. This may be situations involving moderate-to-high levels 
of pain, such as postoperative pain, migraine, appendicitis, 
urinary infection, pyelitis, dislocation of a shoulder, elbow 
or knee, and tooth pain.
Another possible explanation of the findings from this 
study is that gender role expectations of pain influence 
males and females differently when confronted with report-
ing FOP. Previous studies have shown that pain behavior 
is influenced by contextual factors, such as socialization, 
cultural expectations, and feminine and masculine gender 
role expectations.23–25 Klonoff et al reported that males were 
less likely to report pain than females, and furthermore, were 
embarrassed when reporting pain.26 When conducting a study 
where experimenters were instructed to dress up and behave 
in ways meant to elicit gender-related cues, Levine and De 
Simone found that the sex of the experimenter influenced pain 
report in males.27 The results revealed that males reported 
significantly lower pain to female experimenters compared 
to male experimenters. Similar findings have been reported 
later.28 Thus, the importance of gender role stereotypes and 
their possible contribution to pain behavior cannot be entirely 
discounted. Gender role stereotypes might have contributed 
to the findings of the higher FOP in females than in males 
in this study. In this study, the FPQ-III was administered to 
the participants in the laboratory. Participants filled in the 
questionnaire while sitting in the laboratory together with an 
experimenter. When the participants had finished filling in the 
questionnaire it was collected by the experimenter. In many 
cultures, masculine gender roles decreases pain behavior, 
whereas feminine gender roles increase pain expression.29 
Male participants in this study may have underscored FOP, 
possibly due to gender role expectations or stereotypes. How-
ever, as these constructs were not measured, this would be a 
matter of speculation. Future investigations could examine 
this issue further, for example, by measuring level of mas-
culinity and femininity in addition to FOP or designing a 
study where experimenter sex and participant sex is crossed 
and balanced.
The finding that females reported higher FOP on some of 
the Minor and Medical Pain subscales items, in this study, is 
in line with previous findings. Fredrikson et al reported that 
females have higher fear of injections, dentists, and injuries, 
compared to males.30 Females worry, ruminate, and display 
more negative affectivity than males. According to the results 
from this study, females are more afraid of burning their 
fingers, cutting themselves while shaving, having a muscle 
cramp (Minor Pain), and having a wart removed by a doctor 
(Medical Pain), compared to males. However, these differ-
ences did not contribute to sex differences at subscale level. In 
addition to the items with fatal or potential for fatal outcome, 
females were more afraid of being injured by falling, hit or 
burned by an object, food poisoning, and breaking a bone 
(Severe Pain), compared to males. Thus, although there are 
some sex differences on all three subscales, the Minor and 
Medical Pain subscales seem to be better adjusted for sex 
than the Severe Pain subscale.
The FPQ-III is designed to measure FOP,12 but we argue 
that it does not sensitively distinguish between FOP and 
anxiety. The Severe Pain subscale items involving fatal or 
potentially fatal outcome may elicit different psychological 
responses in males and females, and thereby produce the 
differences observed in this and other studies.8–12 Thus, there 
are several potential implications associated with the find-
ings from this study. Pain is not solely a result of nociceptive 
intensity. Psychological factors influence pain experience, 
pain expression, and pain inhibition.26 There is a distinction 
between sensory and affective components of pain, and 





both fear and anxiety constitutes the affective dimension of 
pain. Although fear is related to the immediate and present 
unpleasantness experienced together with pain, anxiety is 
merely associated with fears or worries about the long-term 
implications pain might have.1 If higher FOP measured by the 
FPQ-III reflects fear in males, but anxiety in females, use of 
FPQ-III measures as covariates in experimental and clinical 
studies may lead to erroneous or biased conclusions. Fear 
and anxiety may have opposite effects on pain, illustrated 
by hyperalgesic responses in the presence of anxiety, and 
hypoalgesic responses in the presence of fear.1 This may 
partly explain the finding by Lyby et al.17 In that study it was 
reported that FOP was significantly higher in females than in 
males. Furthermore, FOP was related to reduced pain inhibi-
tion in females, but not in males.9 Those findings may have 
been influenced by sex differences in pain-related anxiety, not 
sex differences in pain-related fear, measured by the FPQ-III. 
However, only overall mean FOP scores was reported, thus 
limiting the possibility to reconcile findings with this study.
If the FPQ-III measure different affective components 
of pain in males and females, our findings may have clinical 
implications as well. Distinguishing between anxiety and 
FOP may thus be of importance, for example, in the work 
with optimizing clinical treatment. Refinement of existing 
models, or development of new ones, should include fear and 
anxiety as separate constructs. However, this study included 
healthy participants only. Thus, results from clinical samples 
may be divergent, and findings from this could be generaliz-
able to nonclinical samples only.
The fairly young age of the participants in our sample 
may represent a limitation, as expression of FOP has been 
found to vary between younger and older populations.15 
Furthermore, this study utilized a Norwegian version of the 
FPQ-III, and had a relatively small sample size. Future studies 
investigating sex differences in FOP measured by the FPQ-
III should include data from other versions across language, 
and age groups. Confirmatory and exploratory factor analytic 
approaches with a focus on sex differences may provide a 
better model, adjusted for the differences induced by sex.
Conclusion
Understanding sex differences in pain is of crucial importance 
to succeed in the development of better and targeted pain 
treatments. This study found that healthy females score higher 
on Severe Pain subscale FPQ-III items than males. The FPQ-
III is designed to measure FOP, but it does not sensitively 
distinguish between FOP and anxiety. Possible explana-
tions are sex differences in psychosocial and  interpretative 
responses to Severe Pain subscale items. Studies have shown 
that anxiety is a better predictor of pain in males than in 
females, and that high levels of FOP reduce pain tolerance in 
females, but not in males. Therefore, future research should 
aim to develop FOP measures that sensitively discriminate 
between fear and anxiety.
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